Triple-agonist research peptide
Retatrutide 30 mg
Retatrutide is a synthetic research peptide characterized by activity across GIP, GLP-1, and glucagon receptor pathways. Its multi-receptor profile has made it a compound of significant interest in contemporary metabolic and receptor-signaling research. Supplied as 30 mg of lyophilized material strictly for in-vitro laboratory research.
Research Material Information
Highlights
- ✓ Triple receptor agonist (GIP / GLP-1 / glucagon), 30mg lyophilized per vial
- ✓ Independently analyzed with batch-specific COA available
- ✓ Lower cost per milligram than the 15mg presentation
- ✓ Supplied strictly for laboratory research use
Storage & Handling
Lyophilized research material should be stored in a cool, dry environment and protected from direct light. For extended storage, maintain under appropriate laboratory storage conditions. Following laboratory reconstitution, maintain refrigerated storage at 2–8°C and protect from light. Do not freeze reconstituted material. Handle in accordance with standard laboratory practices.
Current Batch
- Batch
- PUP-RT30-001
- Laboratory
- ILS Laboratories
- Analysis Date
- Aug 13, 2026
- HPLC Purity
- 98.94%
- Status
- Pass
Keep Looking
Other Compounds
20mg
BPC-157 20 mg
Synthetic research pentadecapeptide
Starting at
$49.99
20mg
TB-500 20 mg
Thymosin-derived research peptide
Starting at
$69.99
100mg
GHK-Cu 100 mg
Copper-binding research peptide
Starting at
$49.99
10mg / 10mg
CJC-1295 (no DAC) + Ipamorelin 10 mg / 10 mg
Dual-peptide research blend
Starting at
$49.99